Prot #I4V-MC-JAIO: A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Baricitinib in Children from 6 Years to Less than 18 Years of Age with Alopecia Areata

Project: Research project

Project Details

StatusActive
Effective start/end date3/12/243/12/27

Funding

  • ICON Clinical Research, LLC (Prot #I4V-MC-JAIO // Prot #I4V-MC-JAIO)
  • Lilly USA, LLC (Prot #I4V-MC-JAIO // Prot #I4V-MC-JAIO)